PuSH - Publikationsserver des Helmholtz Zentrums München

Canis, M.* ; Lechner, A.* ; Mack, B.* ; Zengel, P.* ; Laubender, R.P.* ; Koehler, U.* ; Heissmeyer, V. ; Gires, O.

CD133 is a predictor of poor survival in head and neck squamous cell carcinomas.

Cancer Biomark. 12, 97-105 (2012)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: The pentaspan protein CD133 (Prominin-1) is a predictive marker and part of the signature of tumour-initiating cells (TICs) for various cancer entities. METHODS: The correlation of CD133 expression with clinical parameters was assessed in primary samples of head and neck squamous cell carcinomas (n = 98) and normal mucosas (n = 24). RESULTS: A gradual and inversely proportional correlation between CD133 expression in primary tumours and decreased overall survival was observed, along with a positive correlation with the presence of lymph node metastases. CONCLUSIONS: CD133 has the potential of being a novel clinically relevant prognostic marker for head and neck malignancies, which is possibly involved in regulation of tumourigenicity.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Cd133 ; Hnsccs ; Overall Survival; Node-positive Head ; Cancer Stem-cells ; Adjuvant Radiotherapy ; Oropharyngeal Cancer ; Epidemiology ; Expression ; Protein ; Alpha
ISSN (print) / ISBN 1574-0153
e-ISSN 1875-8592
Zeitschrift Cancer Biomarkers
Quellenangaben Band: 12, Heft: 2, Seiten: 97-105 Artikelnummer: , Supplement: ,
Verlag IOS Press
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed